178 related articles for article (PubMed ID: 17553896)
61. Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection.
Hengst J; Klein AL; Lunemann S; Deterding K; Hardtke S; Falk CS; Manns MP; Cornberg M; Schlaphoff V; Wedemeyer H
J Viral Hepat; 2019 Apr; 26(4):466-475. PubMed ID: 30548086
[TBL] [Abstract][Full Text] [Related]
62. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.
Khakoo SI; Thio CL; Martin MP; Brooks CR; Gao X; Astemborski J; Cheng J; Goedert JJ; Vlahov D; Hilgartner M; Cox S; Little AM; Alexander GJ; Cramp ME; O'Brien SJ; Rosenberg WM; Thomas DL; Carrington M
Science; 2004 Aug; 305(5685):872-4. PubMed ID: 15297676
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.
Crotta S; Stilla A; Wack A; D'Andrea A; Nuti S; D'Oro U; Mosca M; Filliponi F; Brunetto RM; Bonino F; Abrignani S; Valiante NM
J Exp Med; 2002 Jan; 195(1):35-41. PubMed ID: 11781363
[TBL] [Abstract][Full Text] [Related]
64. Frequency and phenotype of circulating Valpha24/Vbeta11 double-positive natural killer T cells during hepatitis C virus infection.
Lucas M; Gadola S; Meier U; Young NT; Harcourt G; Karadimitris A; Coumi N; Brown D; Dusheiko G; Cerundolo V; Klenerman P
J Virol; 2003 Feb; 77(3):2251-7. PubMed ID: 12525661
[TBL] [Abstract][Full Text] [Related]
65. NK cells: natural born killers in the conflict between humans and HCV.
Koziel MJ
Hepatology; 2006 Mar; 43(3):395-7. PubMed ID: 16496351
[No Abstract] [Full Text] [Related]
66. Repressing PU.1 by miR-29a∗ in NK cells of HCV patients, diminishes its cytolytic effect on HCV infected cell models.
Elemam NM; Mekky RY; El-Ekiaby NM; El Sobky SA; El Din MA; Esmat G; Abdelaziz AI
Hum Immunol; 2015 Sep; 76(9):687-94. PubMed ID: 26429314
[TBL] [Abstract][Full Text] [Related]
67. Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection.
Dring MM; Morrison MH; McSharry BP; Guinan KJ; Hagan R; ; O'Farrelly C; Gardiner CM
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5736-41. PubMed ID: 21402922
[TBL] [Abstract][Full Text] [Related]
68. The Clinical Features of Patients with Chronic Hepatitis C Virus Infections Are Associated with Killer Cell Immunoglobulin-Like Receptor Genes and Their Expression on the Surface of Natural Killer Cells.
Podhorzer A; Dirchwolf M; Machicote A; Belen S; Montal S; Paz S; Fainboim H; Podestá LG; Fainboim L
Front Immunol; 2017; 8():1912. PubMed ID: 29354127
[TBL] [Abstract][Full Text] [Related]
69. Innate immune responses in hepatitis C virus-exposed healthcare workers who do not develop acute infection.
Werner JM; Heller T; Gordon AM; Sheets A; Sherker AH; Kessler E; Bean KS; Stevens M; Schmitt J; Rehermann B
Hepatology; 2013 Nov; 58(5):1621-31. PubMed ID: 23463364
[TBL] [Abstract][Full Text] [Related]
70. The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.
Shin EC; Park SH; Nascimbeni M; Major M; Caggiari L; de Re V; Feinstone SM; Rice CM; Rehermann B
J Virol; 2013 Apr; 87(8):4772-7. PubMed ID: 23388706
[TBL] [Abstract][Full Text] [Related]
71. [Role of a host in spontaneous recovery from viral hepatitis C: genetic predetermined factors].
Isaguliants MG; Ozeretskovskaia NN
Vopr Virusol; 2008; 53(6):40-5. PubMed ID: 19172906
[TBL] [Abstract][Full Text] [Related]
72. Natural killer cell function and dysfunction in hepatitis C virus infection.
Holder KA; Russell RS; Grant MD
Biomed Res Int; 2014; 2014():903764. PubMed ID: 25057504
[TBL] [Abstract][Full Text] [Related]
73. IFN-λ3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infection.
Depla M; Pelletier S; Bédard N; Brunaud C; Bruneau J; Shoukry NH
Immun Inflamm Dis; 2016 Sep; 4(3):376-88. PubMed ID: 27621819
[TBL] [Abstract][Full Text] [Related]
74. Natural T cell immunity to intracellular pathogens and nonpeptidic immunoregulatory drugs.
Poccia F; Agrati C; Ippolito G; Colizzi V; Malkovsky M
Curr Mol Med; 2001 Mar; 1(1):137-51. PubMed ID: 11899239
[TBL] [Abstract][Full Text] [Related]
75. [Immune dysregulation mediated by hepatitis C virus infection].
Kobayashi K
Nihon Hansenbyo Gakkai Zasshi; 2005 Sep; 74(3):181-4. PubMed ID: 16248353
[TBL] [Abstract][Full Text] [Related]
76. Do lambda-IFNs IL28A and IL28B act on human natural killer cells?
Krämer B; Eisenhardt M; Glässner A; Körner C; Sauerbruch T; Spengler U; Nattermann J
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E519-20; author reply E521-2. PubMed ID: 21825163
[No Abstract] [Full Text] [Related]
77. Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments.
Cariani E; Pilli M; Barili V; Porro E; Biasini E; Olivani A; Dalla Valle R; Trenti T; Ferrari C; Missale G
Oncoimmunology; 2016 Aug; 5(8):e1154249. PubMed ID: 27622055
[TBL] [Abstract][Full Text] [Related]
78. NK cells in acute hepatitis C.
Nattermann J
J Hepatol; 2011 Aug; 55(2):265-7. PubMed ID: 21236311
[No Abstract] [Full Text] [Related]
79. [Natural killer cells play an important role in hepatitis C infection].
Yang A; Hu D; You H; Wang B
Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):798-800. PubMed ID: 25558504
[No Abstract] [Full Text] [Related]
80. Natural killing activity in patients with spontaneous regression of malignant lymphoma.
Ono K; Kikuchi M; Funai N; Matsuzaki M; Shimamoto Y
J Clin Immunol; 1996 Nov; 16(6):334-9. PubMed ID: 8946278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
